Table 3.
Agent | Total STDs detected, no. (%)† | STDs in HIV group, no. (%)† | STDs in control group, no. (%)† | P |
---|---|---|---|---|
Trichomonas vaginalis | 69 (30.0) | 20 (25.7) | 49 (32.2) | 0.6067 |
Chlamydia trachomatis | 62 (26.9) | 18 (23.1) | 44 (28.9) | 0.0562 |
HSV-2 | 25 (10.9) | 15 (19.2) | 10 (6.6) | 0.3852 |
Neisseria gonorrhoeae | 25 (10.9) | 6 (7.7) | 19 (12.5) | 0.7495 |
Mycoplasma genitalium | 25 (10.9) | 8 (10.2) | 17 (11.2) | 0.9290 |
Treponema pallidum | 16 (6.9) | 8 (10.3) | 8 (5.3) | 0.7148 |
HSV-1 | 8 (3.5) | 3 (3.8) | 5 (3.3) | 0.9714 |
Total | 230 (100.0) | 78 (33.9) | 152 (66.1) | 0.0001‡ |
A total of 556 women were studied (HIV group = 178, control group = 378). STI = sexually transmitted infection; STD = sexually transmitted disease; HIV = human immunodeficiency virus; HSV = herpes simplex virus.
In single or multiple infections.
P < 0.05 was considered significant, by Z test.